Benjamin Lannon, MD

Dr. Benjamin Lannon (he/him) is a board-certified Reproductive Endocrinologist at Everleap Fertility and a Clinical Instructor at Maine Medical Center. He specializes in all aspects of fertility care.
 

Dr. Lannon is double board-certified in Obstetrics and Gynecology/Reproductive Endocrinology and Infertility. He specializes in all aspects of infertility care. In addition to his role at Everleap Fertility, he is also a Clinical Instructor at Harvard Medical School and Maine Medical Center, where he teaches the next generation of fertility experts and performs crucial research that focuses on the use of prediction models to improve medical decision-making in IVF.

His clinical interests include LGBTQ family building, women who have experienced a miscarriage, endocrine disorders affecting reproduction, and surgical treatment to optimize fertility. He has presented and published his research nationally.
Dr. Lannon grew up in Exeter, New Hampshire and received his undergraduate degree from Dartmouth College and his medical degree from Brown University. He also obtained a Master's degree in Evaluative Clinical Sciences from the Dartmouth Institute for Health Policy and Clinical Practice.

He completed his residency in Obstetrics and Gynecology at Beth Israel Deaconess Medical Center and Harvard Medical School - and his fellowship in Reproductive Endocrinology and Infertility at Beth Israel Deaconess Medical Center, Harvard Medical School, and Boston IVF.

Awards

Castle Connolly Top Doctor | 2014-2025
Healthgrades Outstanding Patient Experience Award | 2022-2023
American College of Obstetricians and Gynecologists (ACOG) Fellow
Fertility Equity e-Learning Certified | Morehouse School of Medicine with support from Ferring Pharmaceuticals
 

Publications

1. Choi B, Bosch E, Lannon BM, Leveille MC, Wong WH, Leader A, Pellicer A, Penzias AS, Yao MW. Personalized prediction of first-cycle in vitro fertilization success. Fertil Steril. 2013 Jun; 99(7):1905-11. PMID: 23522806

2. Leader B, Hegde A, Baca Q, Stone K, Lannon B, Seifer DB, Broekmans F, Baker VL. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers. Fertil Steril. 2012 Oct; 98(4):1037-42. PMID: 22771028

3. Lannon BM, Choi B, Hacker MR, Dodge LE, Malizia BA, Barrett CB, Wong WH, Yao MW, Penzias AS. Predicting personalized multiple birth risks after in vitro fertilization-double embryo transfer. Fertil Steril. 2012 Jul; 98(1):69-76. PMID: 22673597

4. Lannon BM, Lee SY. Techniques for removal of the Essure hysteroscopic tubal occlusion device. Fertil Steril. 2007 Aug; 88(2):497.e13-4. PMID: 17397840

5. Barchowsky A, Lannon BM, Elmore LC, Treadwell MD. Increased focal adhesion kinase- and urokinase-type plasminogen activator receptor-associated cell signaling in endothelial cells exposed to asbestos. Environ Health Perspect. 1997 Sep; 105 Suppl 5:1131-7. PMID: 9400712; PMCID: PMC1470137